IntrinsicIntrinsic
← Scroll for more →

Financial Statements — BGMS

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Cash & Equivalents3.793.343.513.844.283.453.142.982.803.385.946.0011.4418.3523.7129.0829.6436.5640.2243.64
Short-term Investments--------------------------4.55------4.48----
Accounts Receivable1.071.191.260.73----0.00--------------------------
Inventory0.970.951.381.37--------------------------------
Total Current Assets5.975.626.266.444.383.713.674.914.847.4411.117.7118.9724.4127.9232.0836.5840.9443.3846.20
Property, Plant & Equipment0.140.140.140.130.000.000.000.000.010.010.020.010.030.030.040.050.060.060.070.07
Goodwill1.571.571.571.57--------------------------------
Total Non-current Assets*0.200.200.201.710.020.020.420.471.331.361.380.483.093.643.113.273.051.651.620.13
Total Assets7.857.568.198.164.403.734.095.386.178.8112.508.1922.0628.0531.0235.3539.6342.5945.0046.33
Accounts Payable0.190.260.620.470.220.114.604.135.203.541.574.742.512.560.982.212.852.121.521.20
Total Current Liabilities0.690.801.331.000.760.666.276.358.358.168.157.197.347.514.355.036.205.293.593.12
Total Non-current Liabilities*0.000.010.010.060.010.010.000.000.020.040.050.010.080.110.110.110.020.030.040.00
Total Liabilities0.690.801.341.060.770.676.276.358.378.208.207.197.427.624.465.146.225.323.643.12
Retained Earnings(455.01)(454.61)(454.41)(444.26)(441.78)(440.46)(439.49)(436.44)(431.23)(428.28)(423.01)(434.48)(411.96)(405.73)(398.74)(393.64)(389.07)(384.96)(379.66)(374.68)
Total Stockholder Equity7.166.766.847.103.633.06(2.17)(0.97)(2.21)0.614.300.6110.1515.9422.0730.2133.4137.2641.3643.22
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Total Revenue0.340.780.670.08----0.000.010.030.030.020.000.000.000.000.000.000.000.000.00
Research & Development----(0.05)0.010.070.820.880.952.803.525.242.025.676.704.414.214.954.594.224.10
Selling, General & Admin0.500.391.251.001.254.210.951.241.581.871.631.631.652.142.051.581.611.941.782.00
Total Operating Expenses0.751.021.751.071.325.041.832.194.385.396.863.657.328.856.475.796.56------
Operating Income(0.42)(0.25)(1.08)(0.99)(1.25)(5.04)(1.83)(2.18)(4.36)(5.36)(6.84)(3.64)(7.32)(8.85)(6.47)(5.78)(6.56)(6.53)(6.00)(6.10)
Pretax Income(0.40)(0.17)(0.61)(0.99)(1.25)(0.08)(1.86)(2.17)(4.30)(5.69)(6.70)(3.67)(7.12)(9.00)(6.11)(5.56)(5.25)(6.49)(5.98)(6.09)
Tax Provision0.010.030.010.000.00--1.19(0.21)(1.35)(0.42)(0.67)(0.41)(1.32)(1.58)(1.01)(0.98)(1.14)(1.20)(1.00)(0.96)
Net Income(0.40)(0.20)(0.61)(0.99)(1.32)(0.08)(3.05)(1.96)(2.95)(5.27)(6.03)(5.45)(5.80)(7.42)(5.10)(4.57)(4.11)(5.29)(4.99)(5.13)
Basic EPS----(4.16)(1.31)(0.98)0.00216.16--------(0.44)(0.47)(0.60)(0.42)(0.46)(0.42)(0.54)----
Diluted EPS----(4.16)(1.31)(0.98)0.00216.16--(2.27)----(0.44)(0.47)(0.60)(0.42)(0.46)(0.42)(0.54)----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow(0.35)(0.28)(0.03)(0.43)(1.06)(3.25)(1.36)(6.63)(0.48)(3.91)(8.63)3.29(6.86)(5.17)(6.97)(1.91)(6.77)(4.55)(6.21)(4.21)
Capital Expenditures0.000.00----------0.00--0.000.010.000.010.000.000.000.000.000.01(0.06)
Free Cash Flow*(0.35)(0.28)----------(6.63)--(3.91)(8.64)3.29(6.87)(5.17)(6.97)(1.92)(6.78)(4.55)(6.22)(4.15)
Investing Cash Flow0.00-0.00----------0.00--0.00(0.01)0.00(0.01)0.000.00-0.00-0.00-0.00(0.01)0.06
Financing Cash Flow0.770.11(0.26)-0.001.883.651.616.21(0.08)1.00(0.15)6.21(0.05)0.041.531.47(0.05)0.892.90(0.05)
← Scroll for more columns →

* Derived from reported values